Is Laboratorios Farmaceuticos Rovi (BME:ROVI) Using Too Much Debt?
Feb 09
Have your own idea? Try our Stock Screener
Spanish (IBEX) Healthcare Sector Analysis
UpdatedFeb 27, 2026
DataAggregated Company Financials
Companies13
- 7D-0.08%
- 3M11.3%
- 1Y16.6%
- YTD5.6%
Over the last 7 days, the Healthcare industry has remained flat, although notably Laboratorios Farmaceuticos Rovi gained 7.0%. The past year has been better, since the industry has gained 17% in that time. As for the next few years, earnings are expected to grow by 25% per annum.
Sector Valuation and Performance
Has the Spanish Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 27 Feb 2026 | €18.5b | €11.3b | €710.3m | 35.1x | 26.1x | 1.6x |
| Sun, 25 Jan 2026 | €18.0b | €11.3b | €706.2m | 30.8x | 25.5x | 1.6x |
| Tue, 23 Dec 2025 | €17.3b | €11.3b | €700.9m | 26.4x | 24.7x | 1.5x |
| Thu, 20 Nov 2025 | €16.3b | €11.3b | €699.4m | 24.7x | 23.3x | 1.4x |
| Sat, 18 Oct 2025 | €17.3b | €11.1b | €621.8m | 25.1x | 27.8x | 1.6x |
| Mon, 15 Sep 2025 | €17.4b | €11.1b | €614.3m | 25.5x | 28.3x | 1.6x |
| Wed, 13 Aug 2025 | €17.0b | €11.1b | €610.7m | 24.7x | 27.8x | 1.5x |
| Fri, 11 Jul 2025 | €16.8b | €11.0b | €507.4m | 21.5x | 33.1x | 1.5x |
| Sun, 08 Jun 2025 | €16.0b | €11.0b | €507.3m | 22.2x | 31.5x | 1.5x |
| Tue, 06 May 2025 | €14.4b | €10.8b | €452.0m | 21.1x | 31.8x | 1.3x |
| Thu, 03 Apr 2025 | €14.0b | €10.8b | €458.7m | 20.3x | 30.6x | 1.3x |
| Sat, 01 Mar 2025 | €15.9b | €10.8b | €414.8m | 21.1x | 38.3x | 1.5x |
| Mon, 27 Jan 2025 | €14.4b | €10.6b | €392.5m | 19.5x | 36.6x | 1.4x |
| Wed, 25 Dec 2024 | €14.4b | €10.6b | €392.4m | 19.1x | 36.8x | 1.4x |
| Fri, 22 Nov 2024 | €15.1b | €10.5b | €393.8m | 19.2x | 38.4x | 1.4x |
| Sun, 20 Oct 2024 | €16.0b | €10.2b | €394.8m | 16.4x | 40.4x | 1.6x |
| Tue, 17 Sep 2024 | €15.2b | €10.2b | €399.9m | 14.4x | 38x | 1.5x |
| Thu, 15 Aug 2024 | €13.8b | €10.2b | €399.9m | 15x | 34.5x | 1.4x |
| Sat, 13 Jul 2024 | €15.8b | €10.0b | €405.9m | 19.8x | 39x | 1.6x |
| Mon, 10 Jun 2024 | €15.6b | €10.0b | €401.4m | 21.1x | 38.8x | 1.6x |
| Wed, 08 May 2024 | €14.6b | €10.0b | €301.0m | 17.7x | 48.6x | 1.5x |
| Fri, 05 Apr 2024 | €14.2b | €10.0b | €292.0m | 21.4x | 48.5x | 1.4x |
| Sun, 03 Mar 2024 | €13.8b | €10.0b | €284.5m | 21x | 48.4x | 1.4x |
| Tue, 30 Jan 2024 | €14.1b | €10.0b | €332.5m | 17.2x | 42.4x | 1.4x |
| Thu, 28 Dec 2023 | €16.4b | €10.0b | €332.6m | 17.3x | 49.2x | 1.6x |
| Sat, 25 Nov 2023 | €15.4b | €10.0b | €331.6m | 17.4x | 46.6x | 1.6x |
| Mon, 23 Oct 2023 | €13.5b | €9.8b | €302.1m | 17.4x | 44.6x | 1.4x |
| Wed, 20 Sep 2023 | €15.7b | €9.8b | €311.0m | 19.3x | 50.5x | 1.6x |
| Fri, 18 Aug 2023 | €15.6b | €9.8b | €311.0m | 19.8x | 50.1x | 1.6x |
| Sun, 16 Jul 2023 | €13.8b | €9.6b | €364.7m | 20.2x | 38x | 1.4x |
| Tue, 13 Jun 2023 | €13.7b | €9.6b | €364.5m | 20.9x | 37.5x | 1.4x |
| Thu, 11 May 2023 | €13.3b | €9.3b | €533.7m | 21.2x | 24.9x | 1.4x |
| Sat, 08 Apr 2023 | €12.4b | €9.3b | €563.7m | 18.9x | 22.1x | 1.3x |
| Mon, 06 Mar 2023 | €14.1b | €9.3b | €564.2m | 20.9x | 25x | 1.5x |
Price to Earnings Ratio
25x
Current Industry PE
- Investors are pessimistic on the Spanish Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 26.1x which is lower than its 3-year average PE of 36.2x.
- The 3-year average PS ratio of 1.5x is lower than the industry's current PS ratio of 1.6x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 8.0% per year over the last three years.
- Revenues for these companies have grown 6.7% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Spanish Healthcare sector?
| ES Market | 2.31% | |
| Healthcare | -0.079% | |
| Medical Equipment | 4.62% | |
| Pharma | 0.084% | |
| Life Sciences | 0% | 0 |
| Biotech | -0.19% | |
| Healthcare Services | -1.52% | |
Industry PE
- Investors are most optimistic about the Healthcare Services industry which is trading above its 3-year average PE ratio of 31.3x.
- Analysts are expecting annual earnings growth of 101.7%, which is higher than its past year's earnings growth of 9.2% per year.
- Investors are most pessimistic about the Medical Equipment industry, which is trading close to its 3-year average of 17.3x.
Forecasted Growth
- Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 102% over the next 5 years.
- This is better than its past earnings growth rate of 9.2% per year.
- In contrast, the Pharma industry is expected to see its earnings grow by 21% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ROVI Laboratorios Farmaceuticos Rovi | €84.60 | 7.0% +€283.9m | 55.8% | PE35.7x | |
| PHM Pharma Mar | €79.05 | 2.0% +€26.7m | -18.2% | PE40x | |
| PRM Prim | €13.60 | 4.6% +€10.2m | 30.8% | PE15.9x | |
| ORY Oryzon Genomics | €3.22 | 2.4% +€5.9m | 11.8% | PS34.7x | |
| RJF Laboratorio Reig Jofre | €2.64 | 1.5% +€3.3m | -1.9% | PE50.6x |